APO Research
Talk to an analyst

APO RESEARCH · REPORT

Encephalitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Encephalitis Vaccine Industry Growth and Trends Forecast to 2032

20 December 2025108 pages

Choose your research edition.

Industry ResearchEncephalitis Vaccine Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Encephalitis Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Encephalitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Encephalitis Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Encephalitis Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Encephalitis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Encephalitis Vaccine include Biken, Valneva, Tiantan Biological Products, Chengdu Institute of Biological Products, Lanzhou Institute of Biological Products, Liaoning Chengda, Sanofi Pasteur, Wuhan Institute of Biological Products and Yisheng Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Encephalitis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Encephalitis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Encephalitis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Encephalitis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Encephalitis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Encephalitis Vaccine Market by Company

Biken

Valneva

Tiantan Biological Products

Chengdu Institute of Biological Products

Lanzhou Institute of Biological Products

Liaoning Chengda

Sanofi Pasteur

Wuhan Institute of Biological Products

Yisheng Bio

Changchun Institute of Biological Products

Zhejiang Tianyuan Bio-Pharmaceutical

Encephalitis Vaccine Segment by Type

Inactivated Vaccine

Live Attenuated Vaccine

Encephalitis Vaccine Segment by Application

Child

Adult

Encephalitis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Encephalitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Encephalitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Encephalitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Encephalitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Encephalitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inactivated Vaccine Table 2. Major Company of Live Attenuated Vaccine Table 3. Global Encephalitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Encephalitis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Encephalitis Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Encephalitis Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Encephalitis Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Encephalitis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Encephalitis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Encephalitis Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Encephalitis Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Encephalitis Vaccine Industry Trends Table 25. Encephalitis Vaccine Industry Drivers Table 26. Encephalitis Vaccine Industry Opportunities and Challenges Table 27. Encephalitis Vaccine Industry Restraints Table 28. Global Encephalitis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Encephalitis Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Encephalitis Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Encephalitis Vaccine Sales Share by Company (2021-2026) Table 32. Global Encephalitis Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Encephalitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Encephalitis Vaccine Major Company Production Sites and Headquarters Table 35. Global Encephalitis Vaccine Company, Product Type & Application Table 36. Global Encephalitis Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Encephalitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Encephalitis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Encephalitis Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Encephalitis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Encephalitis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Encephalitis Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Encephalitis Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Encephalitis Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Encephalitis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Encephalitis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Encephalitis Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Encephalitis Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Encephalitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Encephalitis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Encephalitis Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Encephalitis Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Encephalitis Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Encephalitis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Encephalitis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Encephalitis Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Encephalitis Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Biken Company Information Table 72. Biken Business Overview Table 73. Biken Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Biken Encephalitis Vaccine Product Portfolio Table 75. Biken Recent Development Table 76. Valneva Company Information Table 77. Valneva Business Overview Table 78. Valneva Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Valneva Encephalitis Vaccine Product Portfolio Table 80. Valneva Recent Development Table 81. Tiantan Biological Products Company Information Table 82. Tiantan Biological Products Business Overview Table 83. Tiantan Biological Products Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Tiantan Biological Products Encephalitis Vaccine Product Portfolio Table 85. Tiantan Biological Products Recent Development Table 86. Chengdu Institute of Biological Products Company Information Table 87. Chengdu Institute of Biological Products Business Overview Table 88. Chengdu Institute of Biological Products Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolio Table 90. Chengdu Institute of Biological Products Recent Development Table 91. Lanzhou Institute of Biological Products Company Information Table 92. Lanzhou Institute of Biological Products Business Overview Table 93. Lanzhou Institute of Biological Products Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolio Table 95. Lanzhou Institute of Biological Products Recent Development Table 96. Liaoning Chengda Company Information Table 97. Liaoning Chengda Business Overview Table 98. Liaoning Chengda Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Liaoning Chengda Encephalitis Vaccine Product Portfolio Table 100. Liaoning Chengda Recent Development Table 101. Sanofi Pasteur Company Information Table 102. Sanofi Pasteur Business Overview Table 103. Sanofi Pasteur Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sanofi Pasteur Encephalitis Vaccine Product Portfolio Table 105. Sanofi Pasteur Recent Development Table 106. Wuhan Institute of Biological Products Company Information Table 107. Wuhan Institute of Biological Products Business Overview Table 108. Wuhan Institute of Biological Products Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolio Table 110. Wuhan Institute of Biological Products Recent Development Table 111. Yisheng Bio Company Information Table 112. Yisheng Bio Business Overview Table 113. Yisheng Bio Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Yisheng Bio Encephalitis Vaccine Product Portfolio Table 115. Yisheng Bio Recent Development Table 116. Changchun Institute of Biological Products Company Information Table 117. Changchun Institute of Biological Products Business Overview Table 118. Changchun Institute of Biological Products Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolio Table 120. Changchun Institute of Biological Products Recent Development Table 121. Zhejiang Tianyuan Bio-Pharmaceutical Company Information Table 122. Zhejiang Tianyuan Bio-Pharmaceutical Business Overview Table 123. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolio Table 125. Zhejiang Tianyuan Bio-Pharmaceutical Recent Development Table 126. North America Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 128. North America Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 129. North America Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. North America Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Encephalitis Vaccine Market Share by Country (2021-2026) Table 134. North America Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 136. Europe Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 138. Europe Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 139. Europe Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Encephalitis Vaccine Market Share by Country (2021-2026) Table 144. Europe Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Encephalitis Vaccine Market Share by Country (2021-2026) Table 154. Asia-Pacific Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 156. Latin America Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 158. Latin America Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 159. Latin America Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Encephalitis Vaccine Market Share by Country (2021-2026) Table 164. Latin America Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Encephalitis Vaccine Market Share by Country (2021-2026) Table 174. Middle East and Africa Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Encephalitis Vaccine Distributors List Table 179. Encephalitis Vaccine Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Encephalitis Vaccine Image Figure 2. Global Encephalitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Encephalitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Encephalitis Vaccine Sales (2021-2032) & (K Units) Figure 5. Inactivated Vaccine Image Figure 6. Global Inactivated Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Live Attenuated Vaccine Image Figure 8. Global Live Attenuated Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Encephalitis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Encephalitis Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Encephalitis Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Child Image Figure 24. Global Child Sales YoY Growth (2021-2032) & (K Units) Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Encephalitis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Encephalitis Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Encephalitis Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Encephalitis Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Live Attenuated Vaccine
Applications
  • Child
  • Adult
Companies covered
  • Biken
  • Valneva
  • Tiantan Biological Products
  • Chengdu Institute of Biological Products
  • Lanzhou Institute of Biological Products
  • Liaoning Chengda
  • Sanofi Pasteur
  • Wuhan Institute of Biological Products
  • Yisheng Bio
  • Changchun Institute of Biological Products
  • Zhejiang Tianyuan Bio-Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Encephalitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Encephalitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Encephalitis Vaccine Market by Type
  6. 1.3.1 Inactivated Vaccine
  7. 1.3.2 Live Attenuated Vaccine
  8. 1.4 Global Encephalitis Vaccine Market Size by Type
  9. 1.4.1 Global Encephalitis Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Encephalitis Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Encephalitis Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Encephalitis Vaccine Industry Trends
  2. 2.2 Encephalitis Vaccine Industry Drivers
  3. 2.3 Encephalitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Encephalitis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Encephalitis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Encephalitis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Encephalitis Vaccine Price (2021-2026)
  4. 3.4 Global Encephalitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Encephalitis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Encephalitis Vaccine Company, Product Type & Application
  7. 3.7 Global Encephalitis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Encephalitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Encephalitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Encephalitis Vaccine Tier 1, Tier 2, and Tier 3
4 Encephalitis Vaccine Regional Status and Outlook
  1. 4.1 Global Encephalitis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Encephalitis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Encephalitis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Encephalitis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Encephalitis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Encephalitis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Encephalitis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Encephalitis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Encephalitis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Encephalitis Vaccine by Application
  1. 5.1 Encephalitis Vaccine Market by Application
  2. 5.1.1 Child
  3. 5.1.2 Adult
  4. 5.2 Global Encephalitis Vaccine Market Size by Application
  5. 5.2.1 Global Encephalitis Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Encephalitis Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Encephalitis Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biken
  2. 6.1.1 Biken Company Information
  3. 6.1.2 Biken Business Overview
  4. 6.1.3 Biken Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biken Encephalitis Vaccine Product Portfolio
  6. 6.1.5 Biken Recent Developments
  7. 6.2 Valneva
  8. 6.2.1 Valneva Company Information
  9. 6.2.2 Valneva Business Overview
  10. 6.2.3 Valneva Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Valneva Encephalitis Vaccine Product Portfolio
  12. 6.2.5 Valneva Recent Developments
  13. 6.3 Tiantan Biological Products
  14. 6.3.1 Tiantan Biological Products Company Information
  15. 6.3.2 Tiantan Biological Products Business Overview
  16. 6.3.3 Tiantan Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tiantan Biological Products Encephalitis Vaccine Product Portfolio
  18. 6.3.5 Tiantan Biological Products Recent Developments
  19. 6.4 Chengdu Institute of Biological Products
  20. 6.4.1 Chengdu Institute of Biological Products Company Information
  21. 6.4.2 Chengdu Institute of Biological Products Business Overview
  22. 6.4.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolio
  24. 6.4.5 Chengdu Institute of Biological Products Recent Developments
  25. 6.5 Lanzhou Institute of Biological Products
  26. 6.5.1 Lanzhou Institute of Biological Products Company Information
  27. 6.5.2 Lanzhou Institute of Biological Products Business Overview
  28. 6.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolio
  30. 6.5.5 Lanzhou Institute of Biological Products Recent Developments
  31. 6.6 Liaoning Chengda
  32. 6.6.1 Liaoning Chengda Company Information
  33. 6.6.2 Liaoning Chengda Business Overview
  34. 6.6.3 Liaoning Chengda Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Liaoning Chengda Encephalitis Vaccine Product Portfolio
  36. 6.6.5 Liaoning Chengda Recent Developments
  37. 6.7 Sanofi Pasteur
  38. 6.7.1 Sanofi Pasteur Company Information
  39. 6.7.2 Sanofi Pasteur Business Overview
  40. 6.7.3 Sanofi Pasteur Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi Pasteur Encephalitis Vaccine Product Portfolio
  42. 6.7.5 Sanofi Pasteur Recent Developments
  43. 6.8 Wuhan Institute of Biological Products
  44. 6.8.1 Wuhan Institute of Biological Products Company Information
  45. 6.8.2 Wuhan Institute of Biological Products Business Overview
  46. 6.8.3 Wuhan Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolio
  48. 6.8.5 Wuhan Institute of Biological Products Recent Developments
  49. 6.9 Yisheng Bio
  50. 6.9.1 Yisheng Bio Company Information
  51. 6.9.2 Yisheng Bio Business Overview
  52. 6.9.3 Yisheng Bio Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Yisheng Bio Encephalitis Vaccine Product Portfolio
  54. 6.9.5 Yisheng Bio Recent Developments
  55. 6.10 Changchun Institute of Biological Products
  56. 6.10.1 Changchun Institute of Biological Products Company Information
  57. 6.10.2 Changchun Institute of Biological Products Business Overview
  58. 6.10.3 Changchun Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolio
  60. 6.10.5 Changchun Institute of Biological Products Recent Developments
  61. 6.11 Zhejiang Tianyuan Bio-Pharmaceutical
  62. 6.11.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information
  63. 6.11.2 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
  64. 6.11.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolio
  66. 6.11.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Encephalitis Vaccine Sales by Country
  2. 7.1.1 North America Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Encephalitis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Encephalitis Vaccine Market Size by Country
  6. 7.2.1 North America Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Encephalitis Vaccine Sales by Country
  2. 8.1.1 Europe Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Encephalitis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Encephalitis Vaccine Market Size by Country
  6. 8.2.1 Europe Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Encephalitis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Encephalitis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Encephalitis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Encephalitis Vaccine Sales by Country
  2. 10.1.1 South America Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Encephalitis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Encephalitis Vaccine Market Size by Country
  6. 10.2.1 South America Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Encephalitis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Encephalitis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Encephalitis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Encephalitis Vaccine Value Chain Analysis
  2. 12.1.1 Encephalitis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Encephalitis Vaccine Production Mode & Process
  7. 12.2 Encephalitis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Encephalitis Vaccine Distributors
  10. 12.2.3 Encephalitis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst